Radium-223: A Molecular Smart Bomb for Prostate Cancer Bone Mets
Prostate cancer bone metastasis Roughly 11-12% of men will be diagnosed with prostate cancer (PCa) in their lifetime. Upwards of 20% of treated patients will eventually experience recurrence. One out of 41 PCa patients will die from the disease, since PCa has the ability to metastasize (spread) to distant organs and skeletal sites. In fact, […] CONTINUE
- CATEGORY:
- Bone mets